Skip to content

Search Results

No Matching Results

    Recently Viewed


      HomeLatest newsJohnson & Johnson partners with U.S. Department of Veterans Affairs on #BeThere campaign

      Johnson & Johnson partners with U.S. Department of Veterans Affairs on #BeThere campaign

      In the U.S., an average of 20 Veterans a day die from suicide. This new public service announcement is urgently calling on the public to take notice and action by reaching out to a Veteran who may be in crisis. Join the conversation by using #BeThere on social media, and by visiting for more information on how to reach out and be there for the Veterans and service members in your community.

      Share Article
      share to

      More from Johnson & Johnson

      Meet a nurse who leads clinical trials to find innovative cancer therapies

      Melissa Martinez is a clinical scientist within Johnson & Johnson’s Interventional Oncology R&D group. Not only is she helping to develop lifesaving treatments, she’s redefining what it means to pursue a career in nursing.

      What’s the difference between IBS and IBD?

      These GI conditions sound similar, and they also share some symptoms. But IBS and IBD are distinct disorders—especially when it comes to treatment and the risk of complications.

      What is IL-23?

      This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.
      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.